Mitochondrial disease: genetics and management
- PMID: 26315846
- PMCID: PMC4723631
- DOI: 10.1007/s00415-015-7884-3
Mitochondrial disease: genetics and management
Abstract
Mitochondrial disease is one of the most common groups of genetic diseases with a minimum prevalence of greater than 1 in 5000 in adults. Whilst multi-system involvement is often evident, neurological manifestation is the principal presentation in most cases. The multiple clinical phenotypes and the involvement of both the mitochondrial and nuclear genome make mitochondrial disease particularly challenging for the clinician. In this review article we cover mitochondrial genetics and common neurological presentations associated with adult mitochondrial disease. In addition, specific and supportive treatments are discussed.
Keywords: Acute and chronic neurological presentations; Mitochondrial DNA (mtDNA); Mitochondrial disease; Nuclear genes; Treatment.
Figures
References
-
- Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD). http://omim.org/. Accessed 18 Jun 2015
-
- Ahmad KE, Davis RL, Sue CM (2015) A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family. J Neurol, pp 1–6 - PubMed
-
- Alston CL, Schaefer AM, Raman P, Solaroli N, Krishnan KJ, Blakely EL, He L, Craig K, Roberts M, Vyas A, Nixon J, Horvath R, Turnbull DM, Karlsson A, Gorman GS, Taylor RW. Late-onset respiratory failure due to TK2 mutations causing multiple mtDNA deletions. Neurology. 2013;81:2051–2053. doi: 10.1212/01.wnl.0000436931.94291.e6. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
